miRNA-based potential biomarkers and new molecular insights in ulcerative colitis

J Zhou, J Liu, Y Gao, L Shen, S Li… - Frontiers in Pharmacology, 2021 - frontiersin.org
Ulcerative colitis (UC) is a chronic non-specific inflammatory bowel disease, which usually
manifests as abdominal pain, diarrhea and hematochezia. The disease often recurs and is …

Biomaterial-based delivery of nucleic acids for tissue regeneration

Y Zhuang, W Cui - Advanced Drug Delivery Reviews, 2021 - Elsevier
Gene therapy is a promising novel method of tissue regeneration by stimulating or inhibiting
key signaling pathways. However, their therapeutic applications in vivo are largely limited by …

[HTML][HTML] Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines

I Sadeghian, R Heidari, S Sadeghian, MJ Raee… - European Journal of …, 2022 - Elsevier
Viral infections are a great threat to human health. Currently, there are no effective vaccines
and antiviral drugs against the majority of viral diseases, suggesting the need to develop …

miR-223-3p inhibits human osteosarcoma metastasis and progression by directly targeting CDH6

Q Ji, X Xu, Q Song, Y Xu, Y Tai, SB Goodman, W Bi… - Molecular Therapy, 2018 - cell.com
Cadherin-6 (CDH6) is aberrantly expressed in cancer and closely associated with tumor
progression. However, the functions of CDH6 in human osteosarcoma and the molecular …

[HTML][HTML] MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase

R Bayraktar, M Pichler, P Kanlikilicer, C Ivan… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Triple negative breast cancer (TNBC) is an aggressive type of breast cancer characterized
by the absence of defined molecular targets, including estrogen receptor (ER), progesterone …

Inorganic nanomaterial‐mediated gene therapy in combination with other antitumor treatment modalities

G Lin, RA Revia, M Zhang - Advanced functional materials, 2021 - Wiley Online Library
Cancer is a genetic disease originating from the accumulation of gene mutations in a
cellular subpopulation. Although many therapeutic approaches have been developed to …

Epigenetic reprogramming in cancer: From diagnosis to treatment

PMS Costa, SLA Sales, DP Pinheiro… - Frontiers in cell and …, 2023 - frontiersin.org
Disruption of the epigenetic program of gene expression is a hallmark of cancer that initiates
and propagates tumorigenesis. Altered DNA methylation, histone modifications and ncRNAs …

Tamoxifen resistance: emerging molecular targets

M Rondón-Lagos, VE Villegas, N Rangel… - International journal of …, 2016 - mdpi.com
17β-Estradiol (E2) plays a pivotal role in the development and progression of breast cancer.
As a result, blockade of the E2 signal through either tamoxifen (TAM) or aromatase inhibitors …

Dendrimers show promise for siRNA and microRNA therapeutics

V Dzmitruk, E Apartsin, A Ihnatsyeu-Kachan… - Pharmaceutics, 2018 - mdpi.com
The lack of an appropriate intracellular delivery system for therapeutic nucleic acids (TNAs)
is a major problem in molecular biology, biotechnology, and medicine. A relatively new class …

Dissecting the role of subtypes of gastrointestinal vagal afferents

YB Wang, G De Lartigue, AJ Page - Frontiers in Physiology, 2020 - frontiersin.org
Gastrointestinal (GI) vagal afferents convey sensory signals from the GI tract to the brain.
Numerous subtypes of GI vagal afferent have been identified but their individual roles in gut …